Harmony Biosciences Holdings Inc
(NAS:HRMY)
$
38.41
-0.33 (-0.85%)
Market Cap: 2.24 Bil
Enterprise Value: 1.72 Bil
PE Ratio: 12.47
PB Ratio: 2.23
GF Score: 94/100 Harmony Biosciences Holdings Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 11, 2022 / 04:45PM GMT
Release Date Price:
$47.15
(-5.30%)
Ami Fadia
Needham & Company, LLC - Analyst
Good afternoon, everyone. Thank you for joining us today, and it's my pleasure to be hosting Harmony Bioscience. I have with me Jeff Jacobs (sic - "John Jacobs"), President and CEO of the company; and Sandip Kapadia, who is the CFO.
Questions & Answers
Ami Fadia
Needham & Company, LLC - Analyst
Let me just start by kicking off with a question for John.
John Jacobs
Harmony Biosciences Holdings, Inc. - President & CEO
Thank you, Ami.
Ami Fadia
Needham & Company, LLC - Analyst
John, thank you for joining us today. Perhaps I could start by asking you a broad question. We are past the 18-month mark and closing into about two years since the company IPOed.
John Jacobs
Harmony Biosciences Holdings, Inc. - President & CEO
It's hard to believe, yeah.
Ami Fadia
Needham & Company, LLC - Analyst
Exactly. What
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot